These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23591635)

  • 21. Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV shedding.
    Homans J; Christensen S; Stiller T; Wang CH; Mack W; Anastos K; Minkoff H; Young M; Greenblatt R; Cohen M; Strickler H; Karim R; Spencer LY; Operskalski E; Frederick T; Kovacs A
    J Acquir Immune Defic Syndr; 2012 May; 60(1):99-110. PubMed ID: 22517416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short communication: genital tumor growth factor-β1 levels in HIV-infected Indian women are associated with reduced levels of innate antimicrobial products and increased HIV shedding.
    Thakar M; Patil R; Shukre S; Bichare S; Kadam P; Khopkar P; Ghate M; Paranjape R
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):648-53. PubMed ID: 24547777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of human immunodeficiency virus 1 infection and inflammation on the composition and yield of cervical mononuclear cells in the female genital tract.
    Nkwanyana NN; Gumbi PP; Roberts L; Denny L; Hanekom W; Soares A; Allan B; Williamson AL; Coetzee D; Olivier AJ; Burgers WA; Passmore JA
    Immunology; 2009 Sep; 128(1 Suppl):e746-57. PubMed ID: 19740336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
    Cu-Uvin S; DeLong AK; Venkatesh KK; Hogan JW; Ingersoll J; Kurpewski J; De Pasquale MP; D'Aquila R; Caliendo AM
    AIDS; 2010 Oct; 24(16):2489-97. PubMed ID: 20736815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of hepatitis C virus (HCV) RNA in the genital tracts of HCV/HIV-1-coinfected women.
    Nowicki MJ; Laskus T; Nikolopoulou G; Radkowski M; Wilkinson J; Du WB; Rakela J; Kovacs A
    J Infect Dis; 2005 Nov; 192(9):1557-65. PubMed ID: 16206070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding.
    Al-Harthi L; Kovacs A; Coombs RW; Reichelderfer PS; Wright DJ; Cohen MH; Cohn J; Cu-Uvin S; Watts H; Lewis S; Beckner S; Landay A;
    AIDS; 2001 Aug; 15(12):1535-43. PubMed ID: 11504986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of High-Risk Human Papillomavirus with Genital Tract Mucosal Immune Factors in HIV-Infected Women.
    Buckley N; Huber A; Lo Y; Castle PE; Kemal K; Burk RD; Strickler HD; Einstein MH; Young M; Anastos K; Herold BC
    Am J Reprod Immunol; 2016 Feb; 75(2):146-54. PubMed ID: 26685115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High Levels of Inflammatory Cytokines in the Reproductive Tract of Women with BV and Engaging in Intravaginal Douching: A Cross-Sectional Study of Participants in the Women Interagency HIV Study.
    Alcaide ML; Rodriguez VJ; Brown MR; Pallikkuth S; Arheart K; Martinez O; Roach M; Fichorova RN; Jones DL; Pahwa S; Fischl MA
    AIDS Res Hum Retroviruses; 2017 Apr; 33(4):309-317. PubMed ID: 27897054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levels of Genital Tract Defensins and Cytokines Differ between HIV-Uninfected US and African Women.
    Murphy K; Richardson BA; Dezzutti CS; Marrazzo J; Hillier SL; Hendrix CW; Herold BC
    Am J Reprod Immunol; 2015 Oct; 74(4):313-22. PubMed ID: 26094732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA.
    Cu-Uvin S; Caliendo AM; Reinert S; Chang A; Juliano-Remollino C; Flanigan TP; Mayer KH; Carpenter CC
    AIDS; 2000 Mar; 14(4):415-21. PubMed ID: 10770544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies.
    Fiore JR; Suligoi B; Saracino A; Di Stefano M; Bugarini R; Lepera A; Favia A; Monno L; Angarano G; Pastore G
    AIDS; 2003 Oct; 17(15):2169-76. PubMed ID: 14523273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 RNA in plasma and genital tract secretions in women infected with HIV-1.
    Kovacs A; Chan LS; Chen ZC; Meyer WA; Muderspach L; Young M; Anastos K; Levine AM
    J Acquir Immune Defic Syndr; 1999 Oct; 22(2):124-31. PubMed ID: 10843525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cervicovaginal Immune Activation in Zambian Women With Female Genital Schistosomiasis.
    Sturt AS; Webb EL; Patterson C; Phiri CR; Mweene T; Kjetland EF; Mudenda M; Mapani J; Mutengo MM; Chipeta J; van Dam GJ; Corstjens PLAM; Ayles H; Hayes RJ; Hansingo I; Cools P; van Lieshout L; Helmby H; McComsey GA; Francis SC; Bustinduy AL
    Front Immunol; 2021; 12():620657. PubMed ID: 33737927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma Levels of Secreted Cytokines in Virologically Controlled HIV-Infected Aging Adult Individuals on Long-Term Antiretroviral Therapy.
    Love M; Behrens-Bradley N; Ahmad A; Wertheimer A; Klotz S; Ahmad N
    Viral Immunol; 2024 May; 37(4):202-215. PubMed ID: 38717822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulation in Genital Tract Soluble Immune Mediators in Postmenopausal Women Is Distinct by HIV Status.
    Ghosh M; Jais M; Delisle J; Younes N; Benyeogor I; Biswas R; Mohamed H; Daniels J; Wang C; Young M; Kassaye S
    AIDS Res Hum Retroviruses; 2019 Mar; 35(3):251-259. PubMed ID: 30618272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV RNA levels in plasma and cervical-vaginal lavage fluid in elite controllers and HAART recipients.
    Landay A; Golub ET; Desai S; Zhang J; Winkelman V; Anastos K; Durkin H; Young M; Villacres MC; Greenblatt RM; Norris PJ; Busch MP;
    AIDS; 2014 Mar; 28(5):739-43. PubMed ID: 24326356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cervical human papillomavirus infection and shedding of human immunodeficiency virus in cervicovaginal fluids: a cross-sectional study.
    Fornabaio C; Carvalho AC; Lillo F; Fiore JR; Bergamaschi V; Bigoni S; Puzzi PR; Cristini G; Comelli M; Parisi MR; Matteelli A
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):78-82. PubMed ID: 22706294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract.
    Lahey T; Ghosh M; Fahey JV; Shen Z; Mukura LR; Song Y; Cu-Uvin S; Mayer KH; Wright PF; Kappes JC; Ochsenbauer C; Wira CR
    PLoS One; 2012; 7(6):e38100. PubMed ID: 22675510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemokines are present in the genital tract of HIV-seropositive and HIV-seronegative women: correlation with other immune mediators.
    Spear GT; Sha BE; Saarloos MN; Benson CA; Rydman R; Massad LS; Gilmore R; Landay AL
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):454-9. PubMed ID: 9715841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women.
    Shaheen F; Sison AV; McIntosh L; Mukhtar M; Pomerantz RJ
    J Hum Virol; 1999; 2(3):154-66. PubMed ID: 10413367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.